5-HT1A agonists and dyskinesia in Parkinson's disease: a pharmacological perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

5-HT1A agonists and dyskinesia in Parkinson's disease: a pharmacological perspective

Published:2018-08 Issue:4 Volume:8 Page:207-209
ISSN:1758-2024
Container-title:Neurodegenerative Disease Management
language:en
Short-container-title:Neurodegenerative Disease Management

Author:

Huot Philippe¹²³

Affiliation:

1. Neurodegenerative Disease Group, Montreal Neurological Institute, Montreal, QC, H3A 2B4, Canada

2. Department of Neurology & Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada

3. Division of Neurology, McGill University Health Centre, Montreal, QC, H3A 2B4, Canada

Publisher

Future Medicine Ltd

Subject

Clinical Neurology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nmt-2018-0017

Reference21 articles.

1. Sydney multicenter study of Parkinson's disease: Non‐ L ‐dopa–responsive problems dominate at 15 years

2. The serotonergic system in Parkinson's disease

3. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

4. The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats

5. Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands;Medicinal Research Reviews;2024-05-29

2. Serotonin 5-HT1A receptors and their interactions with adenosine A2A receptors in Parkinson's disease and dyskinesia;Neuropharmacology;2023-03

3. Multimodal imaging study of the 5-HT1A receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia;NeuroImage: Clinical;2023

4. Glycolysis: The Next Big Breakthrough in Parkinson’s Disease;Neurotoxicity Research;2022-09-24

5. Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders;Pharmacology & Therapeutics;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3